Search research articles
Contact Us
Filters
Showing results (121-130 of 147) with videos related to
Page
of 15
Sort By:
Journal of Clinical Pathology
|
September 29, 2005
IHC for Her2 with CBE356 antibody is a more accurate predictor of Her2 gene amplification by FISH than HercepTest in breast carcinoma
R Ainsworth, J M S Bartlett, J J Going, et al.
British Journal of Cancer
|
May 19, 2012
The relationships between cellular components of the peritumoural inflammatory response, clinicopathological characteristics and survival in patients with primary operable colorectal cancer
C H Richards, K M Flegg, C S D Roxburgh, et al.
Neoplasia (New York, N.Y.)
|
April 8, 2004
Zoning of mucosal phenotype, dysplasia, and telomerase activity measured by telomerase repeat assay protocol in Barrett's esophagus
James J Going, Aileen J Fletcher-Monaghan, Lisa Neilson, et al.
BMJ (Clinical Research Ed.)
|
June 20, 1992
Intra-arterial temazepam
R N Scott, J Going, K R Woodburn, et al.
Journal of Cancer Research and Clinical Oncology
|
September 28, 2013
The relationship between genetic profiling, clinicopathological factors and survival in patients undergoing surgery for node-negative colorectal cancer: 10-year follow-up
Arfon G M T Powell, Jenny Ferguson, Fahd Al-Mulla, et al.
Cancer Research
|
February 24, 2001
Lack of telomerase RNA gene hTERC expression in alternative lengthening of telomeres cells is associated with methylation of the hTERC promoter
S F Hoare, L A Bryce, G B Wisman, et al.
Surgical Endoscopy
|
July 13, 2010
Endoscopic mucosal resection for gastroesophageal cancer in a U.K. population. Long-term follow-up of a consecutive series
Andrew B C Crumley, James J Going, Kerryanne McEwan, et al.
Histopathology
|
June 22, 2012
Comparing virtual with conventional microscopy for the consensus diagnosis of Barrett's neoplasia in the AspECT Barrett's chemoprevention trial pathology audit
D S A Sanders, H Grabsch, R Harrison, et al.
Annals of Surgical Oncology
|
March 17, 2011
Interrelationships between tumor proliferative activity, leucocyte and macrophage infiltration, systemic inflammatory response, and survival in patients selected for potentially curative resection for gastroesophageal cancer
Andrew B C Crumley, James J Going, Mustafa Hilmy, et al.
Annals of Surgical Oncology
|
November 23, 2016
The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal Cancer
Stephan B Dreyer, Arfon G M T Powell, Stephen T McSorley, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 147) with videos related to
Sort By:
Page
of 15
Journal of Clinical Pathology
|
September 29, 2005
IHC for Her2 with CBE356 antibody is a more accurate predictor of Her2 gene amplification by FISH than HercepTest in breast carcinoma
R Ainsworth, J M S Bartlett, J J Going, et al.
British Journal of Cancer
|
May 19, 2012
The relationships between cellular components of the peritumoural inflammatory response, clinicopathological characteristics and survival in patients with primary operable colorectal cancer
C H Richards, K M Flegg, C S D Roxburgh, et al.
Neoplasia (New York, N.Y.)
|
April 8, 2004
Zoning of mucosal phenotype, dysplasia, and telomerase activity measured by telomerase repeat assay protocol in Barrett's esophagus
James J Going, Aileen J Fletcher-Monaghan, Lisa Neilson, et al.
BMJ (Clinical Research Ed.)
|
June 20, 1992
Intra-arterial temazepam
R N Scott, J Going, K R Woodburn, et al.
Journal of Cancer Research and Clinical Oncology
|
September 28, 2013
The relationship between genetic profiling, clinicopathological factors and survival in patients undergoing surgery for node-negative colorectal cancer: 10-year follow-up
Arfon G M T Powell, Jenny Ferguson, Fahd Al-Mulla, et al.
Cancer Research
|
February 24, 2001
Lack of telomerase RNA gene hTERC expression in alternative lengthening of telomeres cells is associated with methylation of the hTERC promoter
S F Hoare, L A Bryce, G B Wisman, et al.
Surgical Endoscopy
|
July 13, 2010
Endoscopic mucosal resection for gastroesophageal cancer in a U.K. population. Long-term follow-up of a consecutive series
Andrew B C Crumley, James J Going, Kerryanne McEwan, et al.
Histopathology
|
June 22, 2012
Comparing virtual with conventional microscopy for the consensus diagnosis of Barrett's neoplasia in the AspECT Barrett's chemoprevention trial pathology audit
D S A Sanders, H Grabsch, R Harrison, et al.
Annals of Surgical Oncology
|
March 17, 2011
Interrelationships between tumor proliferative activity, leucocyte and macrophage infiltration, systemic inflammatory response, and survival in patients selected for potentially curative resection for gastroesophageal cancer
Andrew B C Crumley, James J Going, Mustafa Hilmy, et al.
Annals of Surgical Oncology
|
November 23, 2016
The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal Cancer
Stephan B Dreyer, Arfon G M T Powell, Stephen T McSorley, et al.
Page
of 15